ARCHIVES

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Pacific Yew Act Would Result In Duplications, Delays In Taxol Production, Witnesses Say

March 13, 1992

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

Radiation Doesn’t Add Benefit For Early Endometrial Cancer

June 29, 2007

Varmus Projects FY2011 As “Particularly Tight”

November 12, 2010

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014